We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Protein Blood Test Could Predict Future Cognitive Decline

By LabMedica International staff writers
Posted on 18 Jun 2025

Identifying early signs of dementia remains a major clinical challenge, especially among individuals with co-existing conditions like cerebrovascular disease. More...

This is particularly relevant for Southeast Asian populations, where such conditions are more prevalent. In a significant development, researchers have discovered specific proteins in the blood that can predict future cognitive decline and dementia, offering a new pathway for earlier diagnosis and intervention.

The study was conducted by researchers from NUS Medicine (Singapore) on 528 patients attending memory clinics and represents the first of its kind in a local Southeast Asian cohort. Scientists set out to find better diagnostic tools for dementia prediction using advanced proteomic technologies. They analyzed more than 1,000 proteins in the blood, focusing on markers associated with neurodegeneration, inflammation, and vascular dysfunction—key biological processes that contribute to cognitive deterioration.

By characterizing a unique blood protein signature, the researchers identified that individuals with dysregulated levels of these proteins had a higher likelihood of developing dementia and experiencing cognitive decline, independent of age or other medical conditions. These blood proteins also correlated with structural changes in the brain, such as volume shrinkage and signs of small vessel disease, both known early indicators of dementia. Notably, when these biomarkers were assessed alongside existing clinical risk factors, the ability to forecast cognitive decline significantly improved.

To confirm their findings, the team validated the results in an independent cohort of Caucasian patients using cerebrospinal fluid, the liquid surrounding the brain and spinal cord. The same protein markers continued to serve as strong predictors of cognitive decline, suggesting these biomarkers are consistent across biological fluids and ethnically diverse populations. This strengthens the case for their broader application in clinical settings. These findings, published in Alzheimer’s and Dementia, not only enhance diagnostic capabilities but also provide insights into the underlying biological mechanisms of dementia.

The study opens up new opportunities for the development of targeted therapies and preventive strategies, particularly in ageing societies where the burden of dementia is expected to rise sharply. Integrating blood-based biomarker testing with routine clinical evaluations could enable doctors to deliver more precise and timely care to at-risk patients. The research team now plans to further explore the functional role of these proteins in the body and assess their potential as therapeutic targets. This work could ultimately pave the way for novel treatment approaches aimed at halting or slowing the progression of dementia.

“We hope that the outcomes of this work will lead to better prediction models for identifying individuals at risk of cognitive deterioration,” said Dr. Sim Ming Ann, first author of the paper. “With the ability to detect key blood protein changes early, doctors could be better equipped to intervene before significant cognitive decline occurs, potentially slowing disease progression and improving quality of life for patients.”

Related Links:
NUS Medicine


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.